Display options
Share it on

Fed Pract. 2020 Aug;37(8):388-390. doi: 10.12788/fp.0031.

Valproate-Induced Lower Extremity Swelling.

Federal practitioner : for the health care professionals of the VA, DoD, and PHS

Kelley Chuang, Satya Patel

Affiliations

  1. and are Hospitalists at the West Los Angeles VA Medical Center and Assistant Clinical Professors at the University of California, Los Angeles David Geffen School of Medicine.

PMID: 32908348 PMCID: PMC7473731 DOI: 10.12788/fp.0031

Abstract

New-onset severe peripheral edema warrants an extensive evaluation, including congestive heart failure, cirrhosis, nephrotic syndrome, hypoalbuminemia, or lymphatic or venous obstruction.

Copyright © 2020 Frontline Medical Communications Inc., Parsippany, NJ, USA.

Conflict of interest statement

Author disclosures The authors report no actual or potential conflicts of interest with regard to this article.

References

  1. Clin Exp Pharmacol Physiol Suppl. 1995 Dec;22(1):S102-4 - PubMed
  2. Indian J Pharmacol. 2017 Sep-Oct;49(5):399-400 - PubMed
  3. Int J Neuropsychopharmacol. 2009 Aug;12(7):991-3 - PubMed
  4. J Clin Pharmacol. 2010 Apr;50(4):459-71 - PubMed
  5. Hepatology. 1982 Sep-Oct;2(5):591-7 - PubMed
  6. Epilepsia. 1990 Mar-Apr;31(2):211-3 - PubMed
  7. Adv Biomed Res. 2016 Jan 27;5:1 - PubMed
  8. Curr Drug Targets. 2009 Nov;10(11):1052-60 - PubMed
  9. Epilepsia. 2016 Mar;57(3):524-5 - PubMed

Publication Types